PT986393E - Utilizacao de um nitroxido ou de um seu pro-farmaco no tratamento profilactico e terapeutico do cancro - Google Patents
Utilizacao de um nitroxido ou de um seu pro-farmaco no tratamento profilactico e terapeutico do cancroInfo
- Publication number
- PT986393E PT986393E PT98923772T PT98923772T PT986393E PT 986393 E PT986393 E PT 986393E PT 98923772 T PT98923772 T PT 98923772T PT 98923772 T PT98923772 T PT 98923772T PT 986393 E PT986393 E PT 986393E
- Authority
- PT
- Portugal
- Prior art keywords
- cancer
- nitroxide
- therapeutic treatment
- profilactic
- pharmacy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4772497P | 1997-05-27 | 1997-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT986393E true PT986393E (pt) | 2004-06-30 |
Family
ID=21950574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT98923772T PT986393E (pt) | 1997-05-27 | 1998-05-27 | Utilizacao de um nitroxido ou de um seu pro-farmaco no tratamento profilactico e terapeutico do cancro |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0986393B1 (pt) |
JP (3) | JP4856294B2 (pt) |
AT (1) | ATE262330T1 (pt) |
AU (1) | AU746505B2 (pt) |
CA (1) | CA2289017C (pt) |
DE (1) | DE69822626T8 (pt) |
DK (1) | DK0986393T3 (pt) |
ES (1) | ES2216286T3 (pt) |
PT (1) | PT986393E (pt) |
WO (1) | WO1998053835A1 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6096759A (en) * | 1997-09-19 | 2000-08-01 | Georgetown University | Method for treating essential hypertension |
EP1089734A2 (en) * | 1998-06-26 | 2001-04-11 | Georgetown University Medical Center | Use of tempo and tempo derivatives for inducing cell death |
US20040219201A1 (en) * | 2001-12-06 | 2004-11-04 | Yechezkel Barenholz | Tempamine compositions and methods of use |
CA2527522A1 (en) * | 2003-05-29 | 2004-12-09 | Kenneth Chang | Methods of using nitroxides in conjunction with photosensitizers and sonosensitizers |
JP2008528701A (ja) * | 2005-02-02 | 2008-07-31 | ミトス・ファーマシューティカルズ・インコーポレーテッド | 腫瘍性疾患の治療又は予防に用いるためのニトロキシド類 |
US8466130B2 (en) | 2009-09-04 | 2013-06-18 | Colby Pharmaceutical Company | Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers |
EP2139522A2 (en) * | 2007-03-06 | 2010-01-06 | Colby Pharmaceutical Company | Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers |
WO2011066537A1 (en) | 2009-11-30 | 2011-06-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Nitroxide therapy for the treatment of von hippel - lindau disease (vhl) and renal clear cell carcinoma (rcc) |
WO2017165572A1 (en) * | 2016-03-23 | 2017-09-28 | Louis Habash | Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide |
US10231959B2 (en) | 2016-03-23 | 2019-03-19 | Louis Habash | Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide |
US20180078539A1 (en) | 2016-03-23 | 2018-03-22 | Louis Habash | T-cell regulation in t-cell mediated diseases by reducing pathogenic function of th17 in a human subject through treatment with a nitroxide |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4758580A (en) * | 1985-06-26 | 1988-07-19 | Yamanouchi Pharmaceutical Co., Ltd. | Inhibiting growth of tumors with certain substituted phenoxy dimethyl alkanoic acids, esters or salts |
DE59007645D1 (de) * | 1990-06-21 | 1994-12-08 | Edith Dr Huland | Verwendung zytokinhaltiger Aerosole und zytokinhaltige Aerosole selbst. |
US6605619B1 (en) * | 1992-03-20 | 2003-08-12 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Nitroxides as protectors against oxidatives stress |
AU4788396A (en) * | 1995-02-16 | 1996-09-04 | Children's Medical Center Corporation | Inhibition of angiogenesis using interleukin-12 |
-
1998
- 1998-05-27 AU AU75987/98A patent/AU746505B2/en not_active Ceased
- 1998-05-27 CA CA002289017A patent/CA2289017C/en not_active Expired - Fee Related
- 1998-05-27 ES ES98923772T patent/ES2216286T3/es not_active Expired - Lifetime
- 1998-05-27 PT PT98923772T patent/PT986393E/pt unknown
- 1998-05-27 EP EP98923772A patent/EP0986393B1/en not_active Expired - Lifetime
- 1998-05-27 DE DE69822626T patent/DE69822626T8/de active Active
- 1998-05-27 AT AT98923772T patent/ATE262330T1/de active
- 1998-05-27 DK DK98923772T patent/DK0986393T3/da active
- 1998-05-27 WO PCT/US1998/010685 patent/WO1998053835A1/en active IP Right Grant
- 1998-05-27 JP JP50081799A patent/JP4856294B2/ja not_active Expired - Fee Related
-
2009
- 2009-03-16 JP JP2009062262A patent/JP5270413B2/ja not_active Expired - Fee Related
-
2013
- 2013-01-11 JP JP2013003496A patent/JP2013121964A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DK0986393T3 (da) | 2004-07-05 |
EP0986393B1 (en) | 2004-03-24 |
EP0986393A1 (en) | 2000-03-22 |
DE69822626T8 (de) | 2005-02-03 |
WO1998053835A1 (en) | 1998-12-03 |
JP4856294B2 (ja) | 2012-01-18 |
CA2289017C (en) | 2008-07-22 |
DE69822626D1 (de) | 2004-04-29 |
AU746505B2 (en) | 2002-05-02 |
AU7598798A (en) | 1998-12-30 |
JP5270413B2 (ja) | 2013-08-21 |
JP2002500671A (ja) | 2002-01-08 |
ATE262330T1 (de) | 2004-04-15 |
JP2009185034A (ja) | 2009-08-20 |
ES2216286T3 (es) | 2004-10-16 |
CA2289017A1 (en) | 1998-12-03 |
JP2013121964A (ja) | 2013-06-20 |
DE69822626T2 (de) | 2004-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
DK1346041T3 (da) | Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom | |
LU91928I2 (fr) | Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®) | |
DE69523350D1 (de) | Behandlung von hyperproliferativen Gefässerkrankungen | |
ATE144420T1 (de) | Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen | |
DE60124085D1 (de) | Pde-v hemmer zur behandlung von morbus parkinson | |
BR9714677A (pt) | "enantiÈmeros 3-piridila e seu uso como analgésicos" | |
UA41355C2 (uk) | Засіб для лікування нейро-сніду | |
PT986393E (pt) | Utilizacao de um nitroxido ou de um seu pro-farmaco no tratamento profilactico e terapeutico do cancro | |
NO20000446D0 (no) | Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser | |
ES2160643T3 (es) | Composiciones que contienen g-csf y proteina de union al tnf. | |
EA200100716A1 (ru) | Способ профилактики рака молочной железы | |
PT1039900E (pt) | Agentes terapeuticos | |
ATE161725T1 (de) | Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina | |
ATE180669T1 (de) | Verwendung von pregnanderivaten zur behandlung von tumoren | |
BR0110396A (pt) | Métodos para prevenir e tratar alopecia induzida por quimioterapia ou radioterapia | |
NZ511559A (en) | Use of staurosporine derivatives for treating ocular neovascular diseases | |
TR200103561T2 (tr) | Rodanin türevleri ve amiloidlerin önlenmesi ve görüntülenmesinde kullanımları | |
ATE141506T1 (de) | Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff | |
NO923198D0 (no) | Terapeutiske midler | |
DE69633673D1 (de) | Verwendung von Halofuginon zur Herstellung eines Medikaments zur Vorbeugung von Neovaskularisation und zur Behandlung bösartiger Tumore | |
ATE320797T1 (de) | Verwendung von 6-dimethylaminomethyl-1-phenyl- cyclohexanverbindungen zur therapie der harninkontinenz | |
BR9808305A (pt) | Forma hidratada cristalina, processo para a preparação da forma hidratada cristalina, composição farmacêutica, processo de tratamento de um mamìfero, e, processo de tratamento ou de prevenção de dor. | |
NZ337048A (en) | Use of N-[1-methyl-(substituted phenyl)ethyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide derivatives to treat prostate cancer | |
MX9603797A (es) | Agentes terapeuticos para su uso en la terapia del cancer. |